Literature DB >> 9290406

Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes.

S W Dubrey1, K Cha, M Skinner, M LaValley, R H Falk.   

Abstract

OBJECTIVE: To determine whether patients with myocardial amyloidosis due either to AL (primary) amyloid or familial amyloid have distinguishing echocardiographic or electrocardiographic features; and to compare the prevalence of heart failure and survival in the two types of amyloidosis in relation to echocardiographic findings.
DESIGN: Blinded group comparison of randomly selected cases of cardiac amyloidosis.
SETTING: International referral centre for amyloid research and treatment. PATIENTS: 36 patients with cardiac amyloid heart disease, of whom 12 had familial and 24 had primary AL amyloidosis.
RESULTS: Familial and AL echocardiograms were morphologically indistinguishable, with similar left ventricular wall thickness, mean (SD) 15.4 (2.3) nu 15.8 (2.5) mm, respectively; right ventricular wall thickness was also similar between amyloid types: 9.6 (2.8) nu 9.7 (6.5) mm, respectively. Doppler indices of left and right ventricular function, left ventricular volume, and ejection fraction were also similar. Low voltage electrocardiograms (< 0.5 mV) were more common in the AL (16/24, 67%) than in the familial group (4/12, 25%), P < 0.05. The one year survival for familial and AL forms was 92% (11/12) nu 38% (6/24), respectively, with virtually all deaths due to cardiac causes.
CONCLUSIONS: Although cardiac involvement is echocardiographically indistinguishable, cardiac mortality is very different between the two forms of amyloidosis. Preservation of electrocardiographic voltage in familial amyloidosis suggests that the particular biochemical characteristics of distinct types of amyloid fibril have different pathological effects on the myocardium. This distinction becomes critical in the evaluation, treatment, and management of patients who have a diagnosis within the spectrum of the protein deposition diseases.

Entities:  

Mesh:

Year:  1997        PMID: 9290406      PMCID: PMC484868          DOI: 10.1136/hrt.78.1.74

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  20 in total

1.  Assessment of relative sensitivities of noninvasive tests for cardiac amyloidosis in documented cardiac amyloidosis.

Authors:  M Simons; J M Isner
Journal:  Am J Cardiol       Date:  1992-02-01       Impact factor: 2.778

2.  A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves.

Authors:  C ANDRADE
Journal:  Brain       Date:  1952-09       Impact factor: 13.501

3.  Primary systemic amyloidosis: clinical and laboratory features in 474 cases.

Authors:  R A Kyle; M A Gertz
Journal:  Semin Hematol       Date:  1995-01       Impact factor: 3.851

4.  Echocardiographic features in familial amyloidosis with polyneuropathy.

Authors:  C Backman; B O Olofsson
Journal:  Acta Med Scand       Date:  1983

5.  The heart in Portuguese amyloidosis.

Authors:  A F de Freitas
Journal:  Postgrad Med J       Date:  1986-06       Impact factor: 2.401

Review 6.  Doppler echocardiographic assessment of constrictive pericarditis, cardiac amyloidosis, and cardiac tamponade.

Authors:  A L Klein; G I Cohen
Journal:  Cleve Clin J Med       Date:  1992 May-Jun       Impact factor: 2.321

7.  Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation.

Authors:  S Dubrey; A Pollak; M Skinner; R H Falk
Journal:  Br Heart J       Date:  1995-11

8.  Doppler characterization of left ventricular diastolic function in cardiac amyloidosis.

Authors:  A L Klein; L K Hatle; D J Burstow; J B Seward; R A Kyle; K R Bailey; T F Luscher; M A Gertz; A J Tajik
Journal:  J Am Coll Cardiol       Date:  1989-04       Impact factor: 24.094

9.  Amyloid cardiomyopathy: characterization by a distinctive voltage/mass relation.

Authors:  J D Carroll; W H Gaasch; K P McAdam
Journal:  Am J Cardiol       Date:  1982-01       Impact factor: 2.778

10.  Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis.

Authors:  R H Falk; J F Plehn; T Deering; E C Schick; P Boinay; A Rubinow; M Skinner; A S Cohen
Journal:  Am J Cardiol       Date:  1987-02-15       Impact factor: 2.778

View more
  35 in total

Review 1.  Systemic amyloidosis: a challenge for the rheumatologist.

Authors:  Federico Perfetto; Alberto Moggi-Pignone; Riccardo Livi; Alessio Tempestini; Franco Bergesio; Marco Matucci-Cerinic
Journal:  Nat Rev Rheumatol       Date:  2010-06-08       Impact factor: 20.543

Review 2.  Echocardiographic evaluation of cardiac amyloid.

Authors:  Wendy Tsang; Roberto M Lang
Journal:  Curr Cardiol Rep       Date:  2010-05       Impact factor: 2.931

Review 3.  Use of tissue Doppler imaging to identify and manage systemic diseases.

Authors:  Frank Weidemann; Joerg M Strotmann
Journal:  Clin Res Cardiol       Date:  2007-08-29       Impact factor: 5.460

Review 4.  Strain imaging in echocardiography: methods and clinical applications.

Authors:  Gillian C Nesbitt; Sunil Mankad; Jae K Oh
Journal:  Int J Cardiovasc Imaging       Date:  2009-01-15       Impact factor: 2.357

Review 5.  Transthyretin-related amyloidoses and the heart: a clinical overview.

Authors:  Claudio Rapezzi; Candida Cristina Quarta; Letizia Riva; Simone Longhi; Ilaria Gallelli; Massimiliano Lorenzini; Paolo Ciliberti; Elena Biagini; Fabrizio Salvi; Angelo Branzi
Journal:  Nat Rev Cardiol       Date:  2010-05-18       Impact factor: 32.419

6.  Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosis.

Authors:  M A Gertz; M Q Lacy; J A Lust; P R Greipp; T E Witzig; R A Kyle
Journal:  Med Oncol       Date:  1999-07       Impact factor: 3.064

Review 7.  Amyloidotic cardiomyopathy: multidisciplinary approach to diagnosis and treatment.

Authors:  David C Seldin; John L Berk; Flora Sam; Vaishali Sanchorawala
Journal:  Heart Fail Clin       Date:  2011-05-20       Impact factor: 3.179

8.  Role of echocardiography in assessing cardiac amyloidoses: a systematic review.

Authors:  Jun Koyama; Masatoshi Minamisawa; Yoshiki Sekijima; Koichiro Kuwahara; Tsutomu Katsuyama; Kazutoshi Maruyama
Journal:  J Echocardiogr       Date:  2019-02-11

9.  Markedly increased volume of distribution of gadolinium in cardiac amyloidosis demonstrated by T1 mapping.

Authors:  Jeremy Brooks; Christopher M Kramer; Michael Salerno
Journal:  J Magn Reson Imaging       Date:  2013-02-28       Impact factor: 4.813

Review 10.  Echocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment.

Authors:  Maria-Angela Losi; Stefano Nistri; Maurizio Galderisi; Sandro Betocchi; Franco Cecchi; Iacopo Olivotto; Eustachio Agricola; Piercarlo Ballo; Simona Buralli; Antonello D'Andrea; Arcangelo D'Errico; Donato Mele; Susanna Sciomer; Sergio Mondillo
Journal:  Cardiovasc Ultrasound       Date:  2010-03-17       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.